Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy
American Diabetes Association, American Academy of Neurology (1988) Consensus statement: report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 11: 592-597
American Diabetes Association: Standardized measures in diabetic neuropathy
Clinical Practice Recommendations (1995) American Diabetes Association: Standardized measures in diabetic neuropathy. Diabetes Care [Suppl 1] 18: 59-82
Insulin-like growth factor-I and IGF-I receptors in diabetic patients with neuropathy
Migdalis TN, Kalogeropoulou K, Kalantzis L, Nounopoulos C, Bouloukos A, Samartzis M (1995) Insulin-like growth factor-I and IGF-I receptors in diabetic patients with neuropathy. Diabet Med 12: 823-827
Results of a double-blind, placebo-controlled trial of a recombinant human nerve growth factor in diabetic polyneuropathy
Apfel S, Adornato B, Dyek PJ et al. and the Nerve Growth Factor Group (1996) Results of a double-blind, placebo-controlled trial of a recombinant human nerve growth factor in diabetic polyneuropathy. Ann Neurol 40: 954
Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy
Sima AAF, Nathaniel V, Bril V, McEwen TAJ, Greene DA (1988) Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 81: 349-364